FDA Okays Evolocumab Add-On for FH in Children Aged 10 and Up FDA Okays Evolocumab Add-On for FH in Children Aged 10 and Up

The agency has approved the PCSK9 inhibitor for children 10 years of age and older with both homozygous and heterozygous familial hypercholesterolemia.FDA Approvals

Source: Medscape Cardiology Headlines - September 25, 2021 Category: Cardiology Tags: Cardiology News Alert Source Type: news